Unlocking full and fast conversion in photocatalytic carbon dioxide reduction for applications in radio-carbonylation

Harvesting sunlight to drive carbon dioxide (CO2) valorisation represents an ideal concept to support a sustainable and carbon-neutral economy. While the photochemical reduction of CO2 to carbon monoxide (CO) has emerged as a hot research topic, the full CO2-to-CO conversion remains an often-overlooked criterion that prevents a productive and direct valorisation of CO into high-value-added chemicals. Herein, we report a photocatalytic process that unlocks full and fast CO2-to-CO conversion (<10 min) and its straightforward valorisation into human health related field of radiochemistry with carbon isotopes. Guided by reaction-model-based kinetic simulations to rationalize reaction optimisations, this manifold opens new opportunities for the direct access to 11C- and 14C-labeled pharmaceuticals from their primary isotopic sources [11C]CO2 and [14C]CO2

Analiza efectului clinic al aplicării unguentului „Argidină” efectuat în Centrul Republican de leziuni termice

Catedra Ortopedie - Traumatologie şi Сhirurgie în Campanie a USMF "Nicolae Testemitanu”The analysis of obtained clinical results after application of ”Argidina” salve demonstrates its high efficacy in treatment of superficial and profound burns of reduced surfaces. The ”Argidina” salve diminishes the colonies of infection, the bandage is atraumatic, creates optimum conditions of wound regeneration in case of burns of II-IIIAB grade, of sectors of donor wounds

Quality of colonoscopy in an emerging country: A prospective, multicentre study in Russia

Background: The quality of colonoscopy has been related to a higher risk of interval cancer, and this issue has been addressed extensively in developed countries. The aim of our study was to explore the main quality indicators of colonoscopy in a large emerging country. Methods: Consecutive patients referred for colonoscopy in 14 centres were prospectively included between July and October 2014. Before colonoscopy, several clinical and demographic variables were collected. Main quality indicators (i.e. caecal intubation rate, (advanced) adenoma detection rate, rate of adequate cleansing and sedation) were collected. Data were analysed at per patient and per centre level (only for those with at least 100 cases). Factors associated with caecal intubation rate and adenoma detection rate were explored at multivariate analysis. Results: A total of 8829 (males: 35%; mean age: 57 + 14 years) patients were included, with 11 centres enrolling at least 100 patients. Screening (including non-alarm symptoms) accounted for 59% (5188/8829) of the indications. Sedation and split preparation were used in 26% (2294/8829) and 25% (2187/8829) of the patients. Caecal intubation was achieved in 7616 patients (86%), and it was ≥85% in 8/11 (73%) centres. Adenoma detection rate was 18% (1550/8829), and it was higher than 20% in five (45%) centres, whilst it was lower than 10% in four (33%) centres. At multivariate analysis, age (OR: 1.020, 95% CI: 1.015–1.024), male sex (OR: 1.2, 95% CI: 1.1–1.3), alarm symptoms (OR: 1.8, 95% CI: 1.7–2), split preparation (OR: 1.4, 95% CI: 1.2–1.6), caecal intubation rate (OR: 1.6, 95% CI: 1.3–1.9) and withdrawal time measurement (OR: 1.2, 95% CI: 1.6–2.1) were predictors of a higher adenoma detection rate, while adequate preparation (OR: 3.4: 95% CI: 2.9–3.9) and sedation (OR: 1.3; 95% CI: 1.1–1.6) were the strongest predictors of caecal intubation rate. Conclusions: According to our study, there is a substantial intercentre variability in the main quality indicators. Overall, the caecal intubation rate appears to be acceptable in most centres, whilst the overall level of adenoma detection appears low, with less than half of the centres being higher than 20%. Educational and quality assurance programs, including higher rates of sedation and split regimen of preparation, may be necessary to increase the key quality indicators

Flux-splitting schemes for parabolic problems

To solve numerically boundary value problems for parabolic equations with mixed derivatives, the construction of difference schemes with prescribed quality faces essential difficulties. In parabolic problems, some possibilities are associated with the transition to a new formulation of the problem, where the fluxes (derivatives with respect to a spatial direction) are treated as unknown quantities. In this case, the original problem is rewritten in the form of a boundary value problem for the system of equations in the fluxes. This work deals with studying schemes with weights for parabolic equations written in the flux coordinates. Unconditionally stable flux locally one-dimensional schemes of the first and second order of approximation in time are constructed for parabolic equations without mixed derivatives. A peculiarity of the system of equations written in flux variables for equations with mixed derivatives is that there do exist coupled terms with time derivatives

Natural Focal Viral Fevers in the South of the European Part of Russia. Hemorrhagic Fever with Renal syndrome

Objective of the study was to determine the modem epizootic and epidemic peculiarities of hemorrhagic fever with renal syndrome in the south of the European part of Russia. Materials and methods. Data of statistical documentation (epidemiological survey of the infectious disease focus, annual summary reports dated 2009-2018) and epizootic monitoring data submitted by the Rospotrebnadzor Administrations and the Centers of Hygiene and Epidemiology in the constituent entities of the Southern and the North Caucasian Federal Districts were used. Descriptive, analytical methods and retrospective epidemiological analysis were applied. Results and discussion. The circulation of hantavirus in the Volgograd and Astrakhan Regions, Stavropol and Krasnodar Territories, Republics of Adygeya, Kalmykia and Crimea was confirmed. However, two geographically and genetically isolated groups of hantaviruses circulating in the Volgograd Region and in the mountain-foothill zone of the Krasnodar Territory and the Republic of Adygeya were the most epidemiologically significant. Over the period of 2009-2018, 152 HFRS cases with annual fluctuations from 4 to 25 cases were registered. Almost all patients lived in the Volgograd Region (44 cases), where the incidence is caused by the HFRS-Puumala virus, or in the Krasnodar Territory (98 cases), where the HFRS Hantavirus Dobrava-Ap circulates. In HFRS patients with the HFRS-Dobrava-Ap virus severe clinical forms were noted at twice the rate, a fatal outcome in one patient with HFRS-Puumala was recorded. The correct preliminary diagnosis was made for 56.3 per cent of patients in the Volgograd Region and only for 31.7 per cent of patients in the Krasnodar Territory and in the Republic of Adygeya. There are different types of natural HFRS foci in the European south of Russia, they vary by the type of hosts and hantaviruses circulating in them - Puumala, Dobrava, Tula, and Dobrava-Ap. Natural foci where of HFRS-PUU and HFRS-DOB-Ap viruses circulate have high epidemic potential. Severe forms of the HFRS are more often observed in patients with the HFRS-DOB-Ap virus

Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia

BACKGROUND: In a single-center phase 1-2a study, the anti-CD19 chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel produced high rates of complete remission and was associated with serious but mainly reversible toxic effects in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). METHODS: We conducted a phase 2, single-cohort, 25-center, global study of tisagenlecleucel in pediatric and young adult patients with CD19+ relapsed or refractory B-cell ALL. The primary end point was the overall remission rate (the rate of complete remission or complete remission with incomplete hematologic recovery) within 3 months. RESULTS: For this planned analysis, 75 patients received an infusion of tisagenlecleucel and could be evaluated for efficacy. The overall remission rate within 3 months was 81%, with all patients who had a response to treatment found to be negative for minimal residual disease, as assessed by means of flow cytometry. The rates of event-free survival and overall survival were 73% (95% confidence interval [CI], 60 to 82) and 90% (95% CI, 81 to 95), respectively, at 6 months and 50% (95% CI, 35 to 64) and 76% (95% CI, 63 to 86) at 12 months. The median duration of remission was not reached. Persistence of tisagenlecleucel in the blood was observed for as long as 20 months. Grade 3 or 4 adverse events that were suspected to be related to tisagenlecleucel occurred in 73% of patients. The cytokine release syndrome occurred in 77% of patients, 48% of whom received tocilizumab. Neurologic events occurred in 40% of patients and were managed with supportive care, and no cerebral edema was reported. CONCLUSIONS: In this global study of CAR T-cell therapy, a single infusion of tisagenlecleucel provided durable remission with long-term persistence in pediatric and young adult patients with relapsed or refractory B-cell ALL, with transient high-grade toxic effects. (Funded by Novartis Pharmaceuticals; ClinicalTrials.gov number, NCT02435849.